UBS Group AG

Position in RCUS — Arcus Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in RCUS

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$6,239,310

-$3,560,991 QoQ

Shares Held

288,857

-29.8% QoQ

Ownership

0.230%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

24 quarters on record

Voting authority Sole 99.70919866923772.ToString("F0")% Shared 0.ToString("F0")% None 0.2908013307622803.ToString("F0")%

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. RCUS ranks #128 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,239,310	288,857	-29.8%	Shares	Defined	2026-05-05
2025-12-31	$9,800,301	411,259	+145.7%	Shares	Defined	2026-01-29
2025-09-30	$2,276,694	167,404	+80.4%	Shares	Defined	2025-11-13
2025-06-30	$755,400	92,801	-33.4%	Shares	Defined	2025-08-14
2025-03-31	$1,093,873	139,347	+6.3%	Shares	Defined	2025-05-13
2024-12-31	$1,951,542	131,064	+52.6%	Shares	Defined	2025-02-14
2024-09-30	$1,313,349	85,896	+14.4%	Shares	Sole	2024-11-14
2024-06-30	$1,143,970	75,113	-64.0%	Shares	Sole	2024-08-14
2024-03-31	$3,940,803	208,729	+28.5%	Shares	Sole	2024-05-13
2023-12-31	$3,103,444	162,484	+182.4%	Shares	Defined	2024-02-09
2023-09-30	$1,032,788	57,537	-42.1%	Shares	Sole	2023-11-09
2023-06-30	$2,016,660	99,294	+0.6%	Shares	Defined	2023-08-11
2023-03-31	$1,799,503	98,657	+65.1%	Shares	Defined	2023-05-12
2022-12-31	$1,235,588	59,748	+50.5%	Shares	Sole	2023-02-08
2022-09-30	$1,038,447	39,696	-49.2%	Shares	Sole	2022-11-10
2022-06-30	$1,978,496	78,078	-59.7%	Shares	Sole	2022-08-10
2022-03-31	$6,118,821	193,879	+3237.0%	Shares	Defined	2022-05-16
2021-12-31	$235,129	5,810	-72.3%	Shares	Defined	2022-02-14
2021-09-30	$730,735	20,956	+196.7%	Shares	Sole	2021-11-15
2021-06-30	$193,922	7,062	-84.4%	Shares	Sole	2021-08-13
2021-03-31	$1,275,225	45,414	+12141.0%	Shares	Sole	2021-05-12
2020-12-31	$9,631	371	-90.1%	Shares	Defined	2021-02-11
2020-06-30	$92,353	3,733	-82.3%	Shares	Defined	2020-07-31
2020-03-31	$292,271	21,057	—	Shares	Sole	2020-05-01
No filing history on record for this holder in this stock.